MAPS Submits Historic New Drug Application for MDMA-Assisted Therapy of PTSD
MAPS Public Benefit Corporation (MAPS PBC), in a groundbreaking move for psychedelic-assisted therapy, announced their submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for use of MDMA (midomafetamine capsules) for treating post-traumatic stress disorder (PTSD). This NDA marks a first of its kind submission from any psychedelic-assisted therapy and […]
Exploring California’s New Era for Psychedelics and Cannabis: Examining Assembly Bill 1021 and 623
Recent developments in California’s drug policy represent a major step in revamping society’s perception and handling of psychoactive substances. Governor Gavin Newsom just signed two landmark bills, AB 1021 and 623, that address psychoactive drugs like MDMA and psilocybin as well as cannabis. This article will delve into these laws’ details and repercussions and how […]
Blossom: A Model of Interconnected Knowledge in Psychedelic Research
The field of psychedelic research, while not entirely new, is seeing a resurgence in both interest and credibility. As researchers, medical professionals, and the general public become increasingly open to the potential benefits of psychedelics, the need for a reliable source of aggregated information becomes paramount. Blossom, with its commitment to interconnected knowledge, stands out […]
Breaking News: A recent MAPS study suggests that MDMA-Assisted therapy may be a promising treatment for post-traumatic stress disorder (PTSD).
An innovative treatment for those grappling with mild to severe PTSD has been introduced. Research backed by the Multidisciplinary Association for Psychedelic Studies (MAPS) indicates that using 3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) can significantly diminish PTSD symptoms. This could lead to both enhanced mental well-being and decreased societal and economic impacts linked to this challenging condition. Every […]
Psychedelic Therapy US Public Opinion Research Report
Introduction: One emerging area of mental health treatments that has generated much discussion and controversy is Psychedelic Therapy. The use of psychedelic substances in therapeutic settings aims to treat various mental health disorders including depression, PTSD and anxiety; yet its acceptance, perception and knowledge remains variable. This report seeks to provide a comprehensive survey of […]
AMA Guidance Recommends FDA Oversight in Psychedelic Therapy: Balancing Innovation with Safety
The American Medical Association’s (AMA) recent guidance encouraging FDA oversight for medicinal psychedelic use could have significant ramifications on this emerging field of therapy. The move highlights the delicate balance between exploring novel treatment avenues and safeguarding patient safety as America grapples with increasing mental health challenges. Psychotropic substances like psilocybin and MDMA, which were […]
Autism and Psychedelics: Exploring A Neurological Crossroads
Psychedelic substances have long been seen as controversial and unexplored areas in medical research, yet in recent years there has been renewed interest in exploring their therapeutic uses. One area of investigation includes autism spectrum disorder (ASD), which entails social communication challenges and repetitive behaviors; although research into this field remains in its infancy, early […]
Plant Medicine Vs Synthetic Compounds for Psychedelic Treatments
The recent surge of interest in psychedelic research has opened a heated debate regarding plant-based medicines versus synthetic compounds as treatments for mental health disorders. Both approaches present unique advantages and challenges; proponents from either camp arguing their preferred method. This article will highlight key distinctions between plant medicine and synthetic compounds while offering insights […]
Segment Analysis: Examining the Most Promising Sectors of the Psychedelic Industry
The psychedelic industry has experienced dramatic expansion over recent years, fuelled by an upsurge in scientific research and changing public attitudes as well as rising recognition of therapeutic applications of psychedelic substances. This rapid expansion has given birth to multiple promising sectors within the industry each with their own opportunities and challenges; in this article […]
MindMed: Pioneering Next-Generation Mental Health Treatments
Mind Medicine Inc. (MindMed), is a biotechnology company focused on creating innovative mental health treatments. Utilizing psychedelic substances and other novel compounds, MindMed works towards meeting the rising need for effective therapies for depression, anxiety and addiction disorders. In this article we’ll look into MindMed’s mission, research initiatives, and their potential impactful work for future […]